108 related articles for article (PubMed ID: 38958401)
1. Brain structure, amyloid, and behavioral features for predicting clinical progression in subjective cognitive decline.
Liu S; Luo X; Chong JSX; Jiaerken Y; Youn SH; Zhang M; Zhou JH;
Hum Brain Mapp; 2024 Jul; 45(10):e26765. PubMed ID: 38958401
[TBL] [Abstract][Full Text] [Related]
2. Brain amyloid and vascular risk are related to distinct white matter hyperintensity patterns.
Pålhaugen L; Sudre CH; Tecelao S; Nakling A; Almdahl IS; Kalheim LF; Cardoso MJ; Johnsen SH; Rongve A; Aarsland D; Bjørnerud A; Selnes P; Fladby T
J Cereb Blood Flow Metab; 2021 May; 41(5):1162-1174. PubMed ID: 32955960
[TBL] [Abstract][Full Text] [Related]
3. Cross-sectional and longitudinal characterization of SCD patients recruited from the community versus from a memory clinic: subjective cognitive decline, psychoaffective factors, cognitive performances, and atrophy progression over time.
Kuhn E; Moulinet I; Perrotin A; La Joie R; Landeau B; Tomadesso C; Bejanin A; Sherif S; De La Sayette V; Desgranges B; Vivien D; Poisnel G; Chételat G
Alzheimers Res Ther; 2019 Jul; 11(1):61. PubMed ID: 31286994
[TBL] [Abstract][Full Text] [Related]
4. Structural neuroimaging changes associated with subjective cognitive decline from a clinical sample.
Riverol M; Ríos-Rivera MM; Imaz-Aguayo L; Solis-Barquero SM; Arrondo C; Montoya-Murillo G; Villino-Rodríguez R; García-Eulate R; Domínguez P; Fernández-Seara MA
Neuroimage Clin; 2024; 42():103615. PubMed ID: 38749146
[TBL] [Abstract][Full Text] [Related]
5. Prolonged ventricular repolarization associated with mild cognitive impairment and white matter hyperintensities: a cross-sectional study.
Mao M; Wei Y; Wang C; Han X; Liu R; Dong Y; Song L; Cong L; Wang Y; Du Y; Qiu C
Sci Rep; 2024 Jul; 14(1):15162. PubMed ID: 38956440
[TBL] [Abstract][Full Text] [Related]
6. Quantitative MRI of cerebral white matter hyperintensities: A new approach towards understanding the underlying pathology.
Iordanishvili E; Schall M; Loução R; Zimmermann M; Kotetishvili K; Shah NJ; Oros-Peusquens AM
Neuroimage; 2019 Nov; 202():116077. PubMed ID: 31398433
[TBL] [Abstract][Full Text] [Related]
7. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
[TBL] [Abstract][Full Text] [Related]
8. Impacts of baseline biomarkers on cognitive trajectories in subjective cognitive decline: the CoSCo prospective cohort study.
Hong YJ; Ho S; Jeong JH; Park KH; Kim S; Wang MJ; Choi SH; Yang DW;
Alzheimers Res Ther; 2023 Aug; 15(1):132. PubMed ID: 37550761
[TBL] [Abstract][Full Text] [Related]
9. Cognitive reserve and clinical progression in Alzheimer disease: A paradoxical relationship.
van Loenhoud AC; van der Flier WM; Wink AM; Dicks E; Groot C; Twisk J; Barkhof F; Scheltens P; Ossenkoppele R;
Neurology; 2019 Jul; 93(4):e334-e346. PubMed ID: 31266904
[TBL] [Abstract][Full Text] [Related]
10. Periventricular white matter hyperintensities and the risk of dementia: a CREDOS study.
Kim S; Choi SH; Lee YM; Kim MJ; Kim YD; Kim JY; Park JH; Myung W; Na HR; Han HJ; Shim YS; Kim JH; Yoon SJ; Kim SY; Kim DK
Int Psychogeriatr; 2015 Dec; 27(12):2069-77. PubMed ID: 26212042
[TBL] [Abstract][Full Text] [Related]
11. Serotonin Selective Reuptake Inhibitor Treatment Improves Cognition and Grey Matter Atrophy but not Amyloid Burden During Two-Year Follow-Up in Mild Cognitive Impairment and Alzheimer's Disease Patients with Depressive Symptoms.
Brendel M; Sauerbeck J; Greven S; Kotz S; Scheiwein F; Blautzik J; Delker A; Pogarell O; Ishii K; Bartenstein P; Rominger A;
J Alzheimers Dis; 2018; 65(3):793-806. PubMed ID: 30010116
[TBL] [Abstract][Full Text] [Related]
12. Evidence of a Relation Between Hippocampal Volume, White Matter Hyperintensities, and Cognition in Subjective Cognitive Decline and Mild Cognitive Impairment.
Caillaud M; Hudon C; Boller B; Brambati S; Duchesne S; Lorrain D; Gagnon JF; Maltezos S; Mellah S; Phillips N; ; Belleville S
J Gerontol B Psychol Sci Soc Sci; 2020 Aug; 75(7):1382-1392. PubMed ID: 31758692
[TBL] [Abstract][Full Text] [Related]
13. White matter alterations and their associations with biomarkers and behavior in subjective cognitive decline individuals: a fixel-based analysis.
Wei YC; Kung YC; Lin CP; Chen CK; Lin C; Tseng RY; Chen YL; Huang WY; Chen PY; Chong ST; Shyu YC; Chang WC; Yeh CH
Behav Brain Funct; 2024 May; 20(1):12. PubMed ID: 38778325
[TBL] [Abstract][Full Text] [Related]
14. Systemic oxidative stress and cognitive function in Parkinson's disease with different PWMH or DWMH lesions.
Chang TC; Chen YC; Huang YC; Lin WC; Lu CH
BMC Neurol; 2021 Jan; 21(1):16. PubMed ID: 33430806
[TBL] [Abstract][Full Text] [Related]
15. Association of White Matter Hyperintensity Progression with Cognitive Decline in Patients with Amnestic Mild Cognitive Impairment.
Hirao K; Yamashita F; Tsugawa A; Haime R; Fukasawa R; Sato T; Kanetaka H; Umahara T; Sakurai H; Hanyu H; Shimizu S
J Alzheimers Dis; 2021; 80(2):877-883. PubMed ID: 33579856
[TBL] [Abstract][Full Text] [Related]
16. Alteration of regional homogeneity and white matter hyperintensities in amnestic mild cognitive impairment subtypes are related to cognition and CSF biomarkers.
Luo X; Jiaerken Y; Huang P; Xu XJ; Qiu T; Jia Y; Shen Z; Guan X; Zhou J; Zhang M;
Brain Imaging Behav; 2018 Feb; 12(1):188-200. PubMed ID: 28236166
[TBL] [Abstract][Full Text] [Related]
17. Structural integrity in subjective cognitive decline, mild cognitive impairment and Alzheimer's disease based on multicenter diffusion tensor imaging.
Brueggen K; Dyrba M; Cardenas-Blanco A; Schneider A; Fliessbach K; Buerger K; Janowitz D; Peters O; Menne F; Priller J; Spruth E; Wiltfang J; Vukovich R; Laske C; Buchmann M; Wagner M; Röske S; Spottke A; Rudolph J; Metzger CD; Kilimann I; Dobisch L; Düzel E; Jessen F; Teipel SJ;
J Neurol; 2019 Oct; 266(10):2465-2474. PubMed ID: 31227891
[TBL] [Abstract][Full Text] [Related]
18. Association of Subjective Memory Complaints With White Matter Hyperintensities and Cognitive Decline Among Older Adults in Chicago, Illinois.
Dhana A; DeCarli C; Dhana K; Desai P; Krueger K; Evans DA; Rajan KB
JAMA Netw Open; 2022 Apr; 5(4):e227512. PubMed ID: 35426922
[TBL] [Abstract][Full Text] [Related]
19. Spatiotemporal Progression Patterns of Dopamine Availability and Deep Gray Matter Volume in Parkinson Disease-Related Cognitive Impairment.
Oh Y; Kim JS; Lyoo CH; Park G; Kim H
Neurology; 2024 Jul; 103(2):e209498. PubMed ID: 38885485
[TBL] [Abstract][Full Text] [Related]
20. The Influence of Amyloid Burden on Cognitive Decline over 2 years in Older Adults with Subjective Cognitive Decline: A Prospective Cohort Study.
Hong YJ; Park JW; Lee SB; Kim SH; Kim Y; Ryu DW; Park KW; Yang DW
Dement Geriatr Cogn Disord; 2021; 50(5):437-445. PubMed ID: 34736258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
